Switch to:
Progenics Pharmaceuticals Inc (NAS:PGNX)
Additional Paid-In Capital
$588.13 Mil (As of Jun. 2014)

Progenics Pharmaceuticals Inc's quarterly additional paid-in capital increased from Dec. 2013 ($548.51 Mil) to Mar. 2014 ($586.73 Mil) and increased from Mar. 2014 ($586.73 Mil) to Jun. 2014 ($588.13 Mil).

Progenics Pharmaceuticals Inc's annual additional paid-in capital increased from Dec. 2011 ($463.44 Mil) to Dec. 2012 ($493.61 Mil) and increased from Dec. 2012 ($493.61 Mil) to Dec. 2013 ($548.51 Mil).


Definition

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)*Shares Outstanding

Related Terms

Shares Outstanding


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Progenics Pharmaceuticals Inc Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
AdditionalPaidInCapital 153.47306.09321.32401.50422.09439.94453.35463.44493.61548.51

Progenics Pharmaceuticals Inc Quarterly Data

Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14
AdditionalPaidInCapital 466.13468.41469.39493.61505.58541.76547.87548.51586.73588.13
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK